Cubist, Genzyme Corp. General Division deal

The companies will identify compounds that act against pathogenic bacteria

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE